Home › Funds › COBALT CAPITAL MANAGEMENT, INC. › TEVA

COBALT CAPITAL MANAGEMENT, INC. position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

COBALT CAPITAL MANAGEMENT, INC. reported holding 40,000 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.91% of its reported portfolio and ranking #19 among its reported holdings. COBALT CAPITAL MANAGEMENT, INC. has disclosed TEVA holdings in 7 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)40.00K sh
Reported value held$1.58M
Portfolio Weight0.91%
First reportedQ1 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How COBALT CAPITAL MANAGEMENT, INC.'s TEVA position evolved

COBALT CAPITAL MANAGEMENT, INC. first disclosed a stake in TEVA in Q1 2024 at 50,700 shares (US$715K). The position peaked in Q4 2025 at 118,201 shares, worth US$3.7M. Across 7 filings, COBALT CAPITAL MANAGEMENT, INC. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 40,000 shares valued at US$1.6M — a reduction of -20,000 shares quarter over quarter.. Notable position changes include a 79% trim in Q1 2026 (shares rose 12% over the following quarter), a 140% increase in Q2 2026 (shares rose 17% over the following quarter), a 33% trim in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 50.70K $715.38K New
Q4 2024 10.00K $220.40K New
Q2 2025 220.00K $3.69M New
Q4 2025 118.20K $3.69M New
Q1 2026 25.00K $753.00K Reduce
Q2 2026 60.00K $2.03M Add
Q3 2026 40.00K $1.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 48 other funds we track also report a position in TEVA — the largest reported positions include BANK OF MONTREAL /CAN/ (US$4.53B), Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has COBALT CAPITAL MANAGEMENT, INC. held TEVA?

COBALT CAPITAL MANAGEMENT, INC. has disclosed TEVA holdings in 7 of the last 11 reported quarters, going back to Q1 2024.

What is COBALT CAPITAL MANAGEMENT, INC.'s current position in TEVA?

As of Q3 2026, COBALT CAPITAL MANAGEMENT, INC. holds 40.00K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $1.58M, representing 0.91% of its reported portfolio and ranking #19.

Has COBALT CAPITAL MANAGEMENT, INC. been buying or selling TEVA?

In the latest 13F filing (Q3 2026), COBALT CAPITAL MANAGEMENT, INC. reduced its position in TEVA. The position peaked in Q4 2025 at 118.20K shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include BANK OF MONTREAL /CAN/, Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.